SSRI

Recent studies and Food and Drug Administration advisories indicate that taking some antidepressants or seizure/migraine medications during pregnancy may lead to birth defects. Among the drugs being evaluated are:

  1. Zoloft™ / sertraline;
  2. Paxil™ / paroxetine;
  3. Celexa™ / citalopram;
  4. Lexapro™ / escotalopram;
  5. Prozac™ / fluoxetine;
  6. Effexor™ / venlafaxine; and
  7. Topamax™ / topiramate.

Among the birth defects being investigated are congenital issues such as:

  1. heart issues including irregularities in the walls and valves of the heart, atrial or ventricular septal defects (ASD/VSD), pulmonary stenosis or atresia, tricuspid atresia, aortic stenosis, transposition of the great arteries (TGA), double outlet of the right ventricle (DORV), narrowing or coartation of the aorta, and Tetralogy of Fallot;
  2. lung problems including persistent pulmonary hypertension (PPHN);
  3. brain and spinal cord deficiencies including spina bifida
  4. cranial malformations such as craniosynostosis;
  5. abdominal wall issues such as omphalocele;
  6. autism;
  7. anal atresia;
  8. limb defects such as clubfoot; and
  9. cleft lip and/or cleft palate.

If you have questions about your legal rights, contact The Masters Law Firm, lc., 181 Summers Street, Charleston, West Virginia 25301, (304) 342 - 3106.

Footnotes

This website is not affiliated with Forest Labs, Eli Lilly, Wyeth, Pfizer, Ortho-McNeil, Johnson & Johnson, or any other drug manufacturer, or with the Food and Drug Administration. The drug names referenced above are the trademarked property of their respective manufacturers and are listed herein for the sole purpose of identifying the drugs being investigated by this law firm.

This website does not provide medical information or advice. Only your personal physician can advise you regarding your medical care. Do not stop taking any medication without talking to your personal physician.